ArticleGenes & cancer2012

The STAT5 Inhibitor Pimozide Displays Efficacy in Models of Acute Myelogenous Leukemia Driven by FLT3 Mutations.

Erik A Nelson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.